DK0861248T3 - Indolalkylderivater af benzodioxanmethylamin som 5-HT1A receptorligander - Google Patents

Indolalkylderivater af benzodioxanmethylamin som 5-HT1A receptorligander

Info

Publication number
DK0861248T3
DK0861248T3 DK96937782T DK96937782T DK0861248T3 DK 0861248 T3 DK0861248 T3 DK 0861248T3 DK 96937782 T DK96937782 T DK 96937782T DK 96937782 T DK96937782 T DK 96937782T DK 0861248 T3 DK0861248 T3 DK 0861248T3
Authority
DK
Denmark
Prior art keywords
benzodioxane
methylamine
receptor ligands
alkyl derivatives
ht1a receptor
Prior art date
Application number
DK96937782T
Other languages
Danish (da)
English (en)
Inventor
Young Hee Kang
Gary Paul Stack
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0861248T3 publication Critical patent/DK0861248T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK96937782T 1995-11-06 1996-10-29 Indolalkylderivater af benzodioxanmethylamin som 5-HT1A receptorligander DK0861248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US728495P 1995-11-06 1995-11-06
PCT/US1996/017275 WO1997017343A1 (en) 1995-11-06 1996-10-29 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands

Publications (1)

Publication Number Publication Date
DK0861248T3 true DK0861248T3 (da) 2002-04-08

Family

ID=21725271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96937782T DK0861248T3 (da) 1995-11-06 1996-10-29 Indolalkylderivater af benzodioxanmethylamin som 5-HT1A receptorligander

Country Status (21)

Country Link
US (1) US5750724A (ko)
EP (1) EP0861248B1 (ko)
JP (1) JP2000500136A (ko)
KR (1) KR19990067303A (ko)
CN (1) CN1074414C (ko)
AR (1) AR004229A1 (ko)
AT (1) ATE210659T1 (ko)
BR (1) BR9611406A (ko)
CA (1) CA2236678A1 (ko)
DE (1) DE69617995T2 (ko)
DK (1) DK0861248T3 (ko)
ES (1) ES2166470T3 (ko)
HK (1) HK1015366A1 (ko)
HU (1) HUP9902091A3 (ko)
IL (1) IL124095A (ko)
MX (1) MX9803455A (ko)
NZ (1) NZ321821A (ko)
PT (1) PT861248E (ko)
TW (1) TW498075B (ko)
WO (1) WO1997017343A1 (ko)
ZA (1) ZA969221B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US6121307A (en) 1998-04-08 2000-09-19 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
WO2000069424A2 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
TR200200460T2 (tr) 1999-08-23 2002-06-21 Solvay Pharmaceuticals B.V. Yeni fenilpiperazinler
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
AU2002258971A1 (en) 2001-04-24 2002-11-05 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US7041683B2 (en) * 2001-04-24 2006-05-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
US6656951B2 (en) 2001-04-24 2003-12-02 Wyeth 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
US6656950B2 (en) 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
US6667322B2 (en) 2001-10-05 2003-12-23 Wyeth Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
US6911445B2 (en) 2002-09-12 2005-06-28 Wyeth Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
US7227023B2 (en) * 2003-04-30 2007-06-05 Wyeth Quinoline 3-amino chroman derivatives
BRPI0608353A2 (pt) * 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
DK2271634T3 (da) 2008-04-29 2014-05-05 Integrative Res Lab Sweden Ab Modulatorer af dopamin-neurotransmission
US20110105462A1 (en) * 2008-04-29 2011-05-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
EP2271638B1 (en) 2008-04-29 2011-08-31 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulators of dopamine neurotransmission
CN103965186B (zh) * 2013-01-25 2016-05-18 江苏恩华药业股份有限公司 苯并二噁烷-苯并噁（噻）唑哌啶衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE635203A (ko) * 1962-07-20
JPS58219114A (ja) * 1982-06-15 1983-12-20 Mitsubishi Chem Ind Ltd 血圧降下剤
DE3419935A1 (de) * 1984-05-28 1985-11-28 Merck Patent Gmbh, 6100 Darmstadt Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks
US4910302A (en) * 1988-12-19 1990-03-20 American Home Products Corporation Psychotropic polycyclic imides
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride

Also Published As

Publication number Publication date
TW498075B (en) 2002-08-11
AU7524596A (en) 1997-05-29
NZ321821A (en) 1999-07-29
CN1205700A (zh) 1999-01-20
KR19990067303A (ko) 1999-08-16
ZA969221B (en) 1998-05-04
CA2236678A1 (en) 1997-05-15
IL124095A (en) 2001-10-31
CN1074414C (zh) 2001-11-07
AU704216B2 (en) 1999-04-15
JP2000500136A (ja) 2000-01-11
AR004229A1 (es) 1998-11-04
HK1015366A1 (en) 1999-10-15
WO1997017343A1 (en) 1997-05-15
PT861248E (pt) 2002-05-31
EP0861248B1 (en) 2001-12-12
DE69617995D1 (de) 2002-01-24
HUP9902091A3 (en) 2000-03-28
DE69617995T2 (de) 2002-05-16
HUP9902091A2 (hu) 2000-02-28
US5750724A (en) 1998-05-12
BR9611406A (pt) 1999-01-05
ES2166470T3 (es) 2002-04-16
ATE210659T1 (de) 2001-12-15
EP0861248A1 (en) 1998-09-02
MX9803455A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
DK0861248T3 (da) Indolalkylderivater af benzodioxanmethylamin som 5-HT1A receptorligander
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
DK1042287T3 (da) Indolderivater som inhibitorer af faktor Xa
FI973205A (fi) Indolijohdannaisia 5-HT-reseptoriantagonisteina
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK0851855T3 (da) Derivater af melatonin deraf som lægemiddel
DK0591280T3 (da) Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister
DK0630376T3 (da) Kondenserede indolderivater som 5-HT4-receptorantagonister
EE200100246A (et) Asendatud fenüültsükloheksüülühendite uued esterderivaadid
NO985242D0 (no) Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer
NO985225L (no) Indolderivater nyttige som endotelinreseptorantagonister
DK0797542T3 (da) Fremgangsmåde til fremstilling af aluminosilikatderivater
NO995338D0 (no) Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer
DK0991640T3 (da) Syntese af mellemprodukter, der er anvendelige til fremstilling af bromsubstituerede tricykliske forbindelser
DK0912537T3 (da) Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
DK0925285T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
NO974043D0 (no) Indolderivater som EAA-antagonister
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0746979T3 (da) Anvendelse af pyrrolforbindelser som antibegroningsmidler
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK1045691T3 (da) Kombinationer af statin-carboxylalkylether
DK0912556T3 (da) Indolinderivater, der er anvendelige som 5-HT-2C-receptorantagonister
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater